Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 17, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International...
| 1.13K |
—
|
—
| +3.69% | 31.85K |
May 15
| |||||||
Charles River Laboratories International...
| 980 |
—
|
—
| +3.30% | 30.72K |
May 11
| |||||||
Charles River Laboratories International...
| 603 |
—
|
—
| +2.07% | 29.74K |
May 7
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Charles River Laboratories International...
|
0
|
$113.44 | -$431,679.11 |
—
| 29.13K |
May 20
| |||||||
Charles River Laboratories International...
| 1.26K |
—
|
—
| +4.52% | 29.13K |
May 11
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Charles River Laboratories International...
|
0
|
$112.79 | -$826,246.61 |
—
| 27.88K |
Feb 13
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Bristol Myers Squibb Co
| 11K |
$44.72 | $491,920.00 | +2,770.78% | 11.4K |
Jul 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Charles River Laboratories International...
| 2.54K |
—
|
—
| +10.02% | 27.88K |
May 22
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Charles River Laboratories International...
| -1.10K |
$134.71 | -$148,179.00 | -4.16% | 25.34K |
Dec 4
| |||||||
Charles River Laboratories International...
| 1.1K |
$83.85 | -$306,112.27 | +4.34% | 26.44K |
Dec 4
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Charles River Laboratories International...
| 2.75K |
—
|
—
| +12.18% | 25.34K |
May 14
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Charles River Laboratories International...
| -3.61K |
$110.22 | -$397,784.52 | -13.78% | 22.59K |
Jan 2
|
Scheduled
| ||||||
Charles River Laboratories International...
| 3.61K |
$74.93 | -$141,027.36 | +15.98% | 26.2K |
Jan 2
|
Scheduled
| ||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Charles River Laboratories International...
| 2.44K |
—
|
—
| +12.09% | 22.59K |
May 12
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Charles River Laboratories International...
| -6.74K |
$88.00 | -$592,701.71 | -25.05% | 20.15K |
Mar 1
| |||||||
Charles River Laboratories International...
| 6.74K |
$62.67 | -$6,646.20 | +33.42% | 26.89K |
Mar 1
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
|
Feb 21
| |||||||
Bristol Myers Squibb Co
|
0
|
—
|
—
|
—
|
0
| ||||||||
Charles River Laboratories International...
| 2.26K |
—
|
—
| +12.63% | 20.15K |
May 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.